Cargando…
Can urinary CTX-II be a biomarker for knee osteoarthritis?
BACKGROUND: Early diagnosis of knee osteoarthritis (OA) remains a diagnostic challenge. Urinary C-terminal cross-linked telopeptide of type II collagen (urinary CTX-II) is one of the potential OA biomarkers. However, conclusive evidence regarding the use of this biomarker as a tool for early diagnos...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796402/ https://www.ncbi.nlm.nih.gov/pubmed/35236476 http://dx.doi.org/10.1186/s42836-020-0024-2 |
_version_ | 1784641309104930816 |
---|---|
author | Arunrukthavon, Piti Heebthamai, Danai Benchasiriluck, Prapasri Chaluay, Supinda Chotanaphuti, Thanainit Khuangsirikul, Saradej |
author_facet | Arunrukthavon, Piti Heebthamai, Danai Benchasiriluck, Prapasri Chaluay, Supinda Chotanaphuti, Thanainit Khuangsirikul, Saradej |
author_sort | Arunrukthavon, Piti |
collection | PubMed |
description | BACKGROUND: Early diagnosis of knee osteoarthritis (OA) remains a diagnostic challenge. Urinary C-terminal cross-linked telopeptide of type II collagen (urinary CTX-II) is one of the potential OA biomarkers. However, conclusive evidence regarding the use of this biomarker as a tool for early diagnosis is still lacking. The purposes of this study were to compare urinary CTX-II levels in patients with knee OA and in healthy controls, to evaluate the correlation between urinary CTX-II levels, radiographic severity of OA, and patient-reported outcomes and to evaluate the effect of age and gender on urinary CTX-II levels in the Asian populations. METHODS: Two groups were studied. The OA group included 78 patients with knee OA aged > 40 years who met the diagnostic criteria for knee OA described by the American College of Rheumatology (ACR). The control group consisted of 51 healthy participants age > 40 years without clinical or radiographic evidence of knee OA. Bilateral knee radiographs were taken and classified according to the Kellgren and Lawrence (KL) grading system. Urinary CTX-II was measured using a competitive ELISA test and Western Ontario and Mcmaster Universities Arthritis Index (WOMAC) was also recorded in all participants. RESULTS: Urinary CTX-II was significantly higher in the OA group than in the control group (p < 0.001). The severe knee OA group (KL grade 3 and 4) had higher urinary CTX-II levels than mild knee OA group (KL grade 2) but the difference did not reach statistical significance (p = 0.2). There was a moderate correlation between urinary CTX-II levels and KL grades (r = 0.405, p < 0.001) and a weak correlation between urinary CTX-II levels and WOMAC index scores (r = 0.367, p < 0.001). Multiple regression analysis showed that urinary CTX-II was independently associated with KL grades. Whereas age, gender, and WOMAC index had no statistically significant influence on the urinary CTX-II levels. CONCLUSIONS: Patients with knee OA had higher urinary CTX-II levels than healthy controls. Moreover, levels of urinary CTX-II were independently correlated with radiographic severity of knee OA. Age, gender, and patient-reported outcomes exerted no effect on the urinary CTX-II levels. LEVEL OF EVIDENCE: Diagnostic Level III. |
format | Online Article Text |
id | pubmed-8796402 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-87964022022-02-03 Can urinary CTX-II be a biomarker for knee osteoarthritis? Arunrukthavon, Piti Heebthamai, Danai Benchasiriluck, Prapasri Chaluay, Supinda Chotanaphuti, Thanainit Khuangsirikul, Saradej Arthroplasty Research BACKGROUND: Early diagnosis of knee osteoarthritis (OA) remains a diagnostic challenge. Urinary C-terminal cross-linked telopeptide of type II collagen (urinary CTX-II) is one of the potential OA biomarkers. However, conclusive evidence regarding the use of this biomarker as a tool for early diagnosis is still lacking. The purposes of this study were to compare urinary CTX-II levels in patients with knee OA and in healthy controls, to evaluate the correlation between urinary CTX-II levels, radiographic severity of OA, and patient-reported outcomes and to evaluate the effect of age and gender on urinary CTX-II levels in the Asian populations. METHODS: Two groups were studied. The OA group included 78 patients with knee OA aged > 40 years who met the diagnostic criteria for knee OA described by the American College of Rheumatology (ACR). The control group consisted of 51 healthy participants age > 40 years without clinical or radiographic evidence of knee OA. Bilateral knee radiographs were taken and classified according to the Kellgren and Lawrence (KL) grading system. Urinary CTX-II was measured using a competitive ELISA test and Western Ontario and Mcmaster Universities Arthritis Index (WOMAC) was also recorded in all participants. RESULTS: Urinary CTX-II was significantly higher in the OA group than in the control group (p < 0.001). The severe knee OA group (KL grade 3 and 4) had higher urinary CTX-II levels than mild knee OA group (KL grade 2) but the difference did not reach statistical significance (p = 0.2). There was a moderate correlation between urinary CTX-II levels and KL grades (r = 0.405, p < 0.001) and a weak correlation between urinary CTX-II levels and WOMAC index scores (r = 0.367, p < 0.001). Multiple regression analysis showed that urinary CTX-II was independently associated with KL grades. Whereas age, gender, and WOMAC index had no statistically significant influence on the urinary CTX-II levels. CONCLUSIONS: Patients with knee OA had higher urinary CTX-II levels than healthy controls. Moreover, levels of urinary CTX-II were independently correlated with radiographic severity of knee OA. Age, gender, and patient-reported outcomes exerted no effect on the urinary CTX-II levels. LEVEL OF EVIDENCE: Diagnostic Level III. BioMed Central 2020-02-10 /pmc/articles/PMC8796402/ /pubmed/35236476 http://dx.doi.org/10.1186/s42836-020-0024-2 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Arunrukthavon, Piti Heebthamai, Danai Benchasiriluck, Prapasri Chaluay, Supinda Chotanaphuti, Thanainit Khuangsirikul, Saradej Can urinary CTX-II be a biomarker for knee osteoarthritis? |
title | Can urinary CTX-II be a biomarker for knee osteoarthritis? |
title_full | Can urinary CTX-II be a biomarker for knee osteoarthritis? |
title_fullStr | Can urinary CTX-II be a biomarker for knee osteoarthritis? |
title_full_unstemmed | Can urinary CTX-II be a biomarker for knee osteoarthritis? |
title_short | Can urinary CTX-II be a biomarker for knee osteoarthritis? |
title_sort | can urinary ctx-ii be a biomarker for knee osteoarthritis? |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796402/ https://www.ncbi.nlm.nih.gov/pubmed/35236476 http://dx.doi.org/10.1186/s42836-020-0024-2 |
work_keys_str_mv | AT arunrukthavonpiti canurinaryctxiibeabiomarkerforkneeosteoarthritis AT heebthamaidanai canurinaryctxiibeabiomarkerforkneeosteoarthritis AT benchasiriluckprapasri canurinaryctxiibeabiomarkerforkneeosteoarthritis AT chaluaysupinda canurinaryctxiibeabiomarkerforkneeosteoarthritis AT chotanaphutithanainit canurinaryctxiibeabiomarkerforkneeosteoarthritis AT khuangsirikulsaradej canurinaryctxiibeabiomarkerforkneeosteoarthritis |